Skip to main content
Premium Trial:

Request an Annual Quote

James Gibson, Greg Schiffman, Geert Nygaard, Rodney Gonsalves, Hilliard Terry

James Gibson will receive an annual base salary $230,000 for serving as principal accounting officer of Affymetrix, the firm said last week in an 8-K filing with the US Securities and Exchange Commission.
In addition, Affy granted Gibson 7,500 restricted shares of its common stock, of which 2,500 shares will vest on each of the second, third, and fourth anniversaries of the Jan. 17 grant date, the company said.
Gibson was promoted to principal accounting officer following the departure last month of Greg Schiffman as chief financial offer (see BAN 12/19/2006).

Epigenomics last week said it has named Geert Nygaard as its new CEO.
Nygaard comes to the company from Abbott, where he was managing director and management board member. Nygaard also has worked at the Swiss company Dako and at Beckman Instruments.

Agilent Technologies has promoted Rodney Gonsalves to the post of director of investor relations, the company said last week.

Gonsalves recently served Agilent as controller of corporate governance and customer financing in the company’s global infrastructure organization. He succeeds Hilliard Terry, who was named vice president and treasurer last November.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.